维立志博-B大跌5.09% LBL-034 II期试验首例患者近日成功用药

港美通
Sep 02, 2025

9月2日11:03,维立志博-B(09887)大幅跳水5.09%,该股报63.400港元,最高报67.450港元,最低报63.400港元,成交量19.04万股,成交额1240.44万港元。消息面上,维立志博-B近日公布了2025年中期业绩,研发成本约1.32亿元,同比增长56.9%;期内亏损约1.66亿元,同比减少7.8%;每股亏损1.06元。公告称,研发成本增长主要由于:(i)CMC开发里程碑...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10